NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE7447.4591.3 (+1.24 %)
PREV CLOSE ( ) 7356.15
OPEN PRICE ( ) 7305.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1147
TODAY'S LOW / HIGH ( )7263.05 7476.65
52 WK LOW / HIGH ( )2083.1 7794
NSE7457.65100 (+1.36 %)
PREV CLOSE( ) 7357.65
OPEN PRICE ( ) 7349.90
BID PRICE (QTY) 7457.65 (3)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 10449
TODAY'S LOW / HIGH( ) 7241.10 7487.50
52 WK LOW / HIGH ( )2082.35 7790
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax2157.46821.631053.34529.23203.37
Adjustment760.53663.04400.85582.76391.06
Changes In working Capital-109.60-675.85492.17-491.73154.70
Cash Flow after changes in Working Capital2808.40808.821946.35620.25749.14
Cash Flow from Operating Activities2372.12603.891893.62573.41699.07
Cash Flow from Investing Activities-614.99-955.16-844.24-486.80-772.29
Cash Flow from Financing Activities-1357.96377.22-1136.60-54.80119.77
Net Cash Inflow / Outflow399.1825.94-87.2231.8146.55
Opening Cash & Cash Equivalents50.9124.36112.0479.3832.88
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange Fluctuations4.070.62-0.460.85-0.05
Closing Cash & Cash Equivalent454.1650.9124.36112.0479.38

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.